TotalMarketCap

Palvella Therapeutics

PVLANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.476 B

$156.26 -3.71%

Close of 6 Nov 2026

As of 6 Nov 2026, Palvella Therapeutics (PVLA) has a market capitalization of $2.48B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$41.7M

Loss-making

Shares outstanding

14,618,457

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #80Zai LabZLAB$2.54B
  2. #81HUTCHMED (China)HCM$2.48B
  3. #82Palvella TherapeuticsPVLA$2.48B
  4. #83Xeris BiopharmaXERS$2.37B
  5. #84MBX BiosciencesMBX$2.34B

What if Palvella Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,782,100

Per share 11,405× higher

Bitcoin $1.53T

$96,426.35

Per share 617× higher

Apple $5.02T

$316,558.71

Per share 2,026× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Palvella Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.